Online Inquiry

Please note that we are not a pharmacy or clinic, so we are unable to see patients and do not offer diagnostic and treatment services for individuals.

Apoptosis

Inquiry

Overview

(Source: Bioicons, free)

Apoptosis is a genetically controlled, cell-autonomous, orderly process of cell death that involves gene activation, gene expression, and gene regulation. In multicellular organisms, apoptosis plays an important role in the removal of unwanted or abnormal cells, the maintenance of a stable internal environment, and the development of multiple systems. Too much apoptosis leads to atrophy, while not enough apoptosis leads to uncontrolled cell proliferation. Altered apoptosis has been associated with the development of diseases, including viral infections, cancer, neurodegenerative diseases, and autoimmune diseases. Protheragen offers clients a wide range of compounds for mechanistic studies of apoptosis and obesity.

Enriched Apoptosis Boosts Your Anti-Obesity Research

Adipocyte apoptosis plays a role in the onset and development of obesity. For example, adipokines (a variety of active factors secreted mainly by adipocytes) affect the metabolic state of the body by regulating various functions such as insulin secretion, gene expression, and apoptosis in pancreatic β-cells.

Fig.1 Apoptosis is triggered through two major pathways referred to as the intrinsic and extrinsic pathways.Fig.1 Two triggering pathways for apoptosis. (Bertheloot, et al., 2021)

Our company offers a wide range of apoptotic compounds such as apoptosis controllers, apoptosis activators, apoptosis inhibitors, apoptosis modulators, and apoptosis inducers to facilitate our clients' anti-obesity programs. Our high-quality compounds have been praised by many clients.

Our apoptosis products have a wide range of metabolic pathways, targets, and receptors to meet the diverse research needs of our clients. If you don't find a specific target, we are ready to help you!

Targets

5-HT receptor ABC AChE AChR ADC cytotoxin
Adrenergic receptor Akt AMPK Antibacterial Antibiotic
Antioxidant Antiviral Apoptosis Aromatase ASK
ATM/ATR ATPase Aurora kinase Autophagy BCL
Bcr-Abl Beta Amyloid Calcium channel CaMK Casein kinase
Caspase CDK c-Fms c-Kit c-Met/HGFR
c-Myc COX c-RET CSF-1R cytohesin
Dehydrogenase DNA/RNA synthesis DNA-PK Dopamine receptor eIF
Endogenous metabolite ERK Estrogen receptor/ERR Fatty acid synthase Ferroptosis
FLT FXR GSK-3 HBV HDAC
Hedgehog/Smoothened Histamine receptor HIV protease HSP IDO/TDO
IL receptor Influenza virus Interleukin Interleukins IκB/IKK
JAK JNK KLF Lipid Lipoxygenase
lysosomal autophagy MAO MAPK Mdm2 MEK
Microtubule associated Mitochondrial metabolism Mitophagy MLK Monoamine oxidase
mTOR NADPH NF-κB NO synthase NOD
Nrf2 OXPHOS p38 MAPK P450 p53
Parasite PARP PDE PDGFR PDK
PERK PGE synthase P-gp Phospholipase PI3K
PKA PKC PLK Potassium channel PPAR
Prostaglandin receptor Raf Ras Reactive oxygen species Reductase
Rho RIP kinase ROS S1P receptor S6 Kinase
Sigma receptor Sirtuin Smo Sodium channel Src
STAT Stearoyl-CoA desaturase (SCD) TGF-beta/Smad TNF TOPK
Topoisomerase Transferase Trk receptor TRP/TRPV channel Tyrosinase
Tyrosine kinases VEGFR Virus protease Wnt/beta-catenin

Publication

Technology: Hydroxymethylated DNA immunoprecipitation sequencing (hMeDIP-seq), Gene set enrichment analysis, Fluorescence microscopy, Flow-cytometer

Journal: Stem Cell Research & Therapy

Published: 2023

IF: 7.1

Results: This paper focuses on the effects of obesity and dyslipidemia on DNA hydroxymethylation (5hmC) modifications of apoptosis- and senescence-related genes in porcine adipose-derived mesenchymal stem cells (MSCs) and assesses the reversible regulatory effects of vitamin C on these modifications. The researchers identified 467 hyperhydroxymethylated and 591 hypohydroxymethylated gene loci in MSCs of the obese group, which are associated with biological processes such as apoptosis, cell proliferation, and senescence. Moreover, the researchers found that vitamin C treatment partially reversed the aberrant 5hmC modifications in the obese group MSCs, restoring them to the levels found in lean pig MSCs.

Fig.2 Functional assays indicate increased senescence in swine obese-MSCs.Fig.2 Analysis of swine obese-MSCs senescence function. (Glasstetter, et al., 2023)

Applications

  • Apoptosis-related compounds play an important role in the study of the mechanisms of various diseases, such as cancer, metabolic diseases, immune diseases, and neurodegenerative diseases.
  • Apoptosis can be used to screen compounds with potential anti-obesity activity using high-throughput screening (HTS) and high-content screening (HCS).
  • Apoptosis-related compounds can be used for anti-obesity drug development and efficacy optimization.

Frequently Asked Questions

  1. What is the biological function of apoptosis?
    • Removal of useless or redundant cells
    • Removal of cells that no longer serve a purpose
    • Removal of cells that are not developing properly
    • Removing some harmful cells
  2. What is the difference between apoptosis and necrosis?

    Apoptosis and necrosis have similar endpoints but very different processes. Necrosis is triggered by strong external factors, leading to disorderly cell death, which is characterized by cell expansion, membrane rupture, content leakage, and insufficient DNA degradation, triggering a significant inflammatory response. Apoptosis, on the other hand, is an orderly process of cellular response to environmental changes, whether physiological or pathological stimuli, prompting orderly changes and cell death, which is distinctly different from the characteristics of necrosis.

    Fig.3 Molecular mechanism of apoptosis and necroptosis.Fig.3 Schematic diagram of apoptosis and necrosis. (Dhuriya &Sharma, 2018)

Protheragen not only provides compounds related to apoptosis but also offers a range of services, including but not limited to apoptosis signaling, apoptosis effector molecules, apoptosis-disease relationship, and screening of apoptosis inhibitors and promoters. Please feel free to contact us.

References

  1. Glasstetter, L.M.; et al. Obesity and dyslipidemia are associated with partially reversible modifications to DNA hydroxymethylation of apoptosis-and senescence-related genes in swine adipose-derived mesenchymal stem/stromal cells. Stem Cell Research & Therapy. 2023, 14(1): 143. (CC BY 4.0)
  2. Dhuriya, Y.K.; Sharma, D. Necroptosis: a regulated inflammatory mode of cell death. Journal of neuroinflammation. 2018, 15: 1-9. (CC BY 4.0)
  3. Bertheloot, D.; et al.. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cellular & Molecular Immunology. 2021, 18(5): 1106-1121. (CC BY 4.0)
View more

Apoptosis Products

By Target
By Receptor
By Identity
By Formulation
By Solubility
OSI-930
  • CAS No.: 728033-96-3
  • Pathways: Apoptosis; Angiogenesis; MAPK; Tyrosine kinase/adaptors
  • Targets: CSF-1R; Src; c-Kit; Apoptosis; Raf; c-Fms; VEGFR; FLT
  • Receptors: Apoptosis; c-Fms; c-Kit; C-Raf; CSF-1R; FLT1; Lck; VEGFR; VEGFR2 (KDR)
OSI-930
Lenvatinib
  • CAS No.: 417716-92-8
  • Pathways: Apoptosis; Angiogenesis; Tyrosine kinase/adaptors
  • Targets: VEGFR; FGFR; c-Kit; PDGFR; c-RET
  • Receptors: c-Kit; FGFR; FGFR1; PDGFR; PDGFRβ; RET; VEGFR; VEGFR1/FLT1; VEGFR2/KDR; VEGFR3/FLT4
Lenvatinib
FLLL32
  • CAS No.: 1226895-15-3
  • Pathways: Apoptosis; Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem cells
  • Targets: JAK; STAT; Apoptosis
  • Receptors: Apoptosis; JAK; JAK2; STAT
FLLL32
ISRIB
  • CAS No.: 548470-11-7
  • Pathways: Apoptosis
  • Targets: PERK
  • Receptors: PERK
ISRIB
MGCD-265 analog
  • CAS No.: 875337-44-3
  • Pathways: Apoptosis; Angiogenesis; Tyrosine kinase/adaptors
  • Targets: Apoptosis; VEGFR; c-Met/HGFR
  • Receptors: Apoptosis; c-Met/HGFR; Met; RON; VEGFR; VEGFR1; VEGFR2; VEGFR3
MGCD-265 analog
Secoisolariciresinol
  • CAS No.: 29388-59-8
  • Pathways: Apoptosis
  • Targets: TNF
  • Receptors: TNF-α
Secoisolariciresinol
Glycitein
  • CAS No.: 40957-83-3
  • Pathways: Apoptosis
  • Targets: Apoptosis
  • Receptors: Apoptosis
Glycitein
Tectorigenin
  • CAS No.: 548-77-6
  • Pathways: Apoptosis
  • Targets: Apoptosis
  • Receptors: Apoptosis inducer
Tectorigenin
FB23-2
  • CAS No.: 2243736-45-8
  • Pathways: Apoptosis
  • Targets: Apoptosis
  • Receptors: Apoptosis; mRNA N6-methyladenosine (m6A) demethylase FTO
FB23-2
Urolithin A
  • CAS No.: 1143-70-0
  • Pathways: Apoptosis
  • Targets: Apoptosis
  • Receptors: Apoptosis; Autophagy; DNA synthesis; DNA/RNA synthesis; Drug metabolite; Endogenous metabolite; Reactive oxygen species
Urolithin A
Inquiry

Copyright © Protheragen. All rights reserves.